An observational retrospective study to evaluate the burden of respiratory syncytial virus (RSV) infection in children and adolescents ≤17 years of age in Ontario
Summary
Client: IQVIA Solutions Canada Inc.
Project ID: P2023-177/ 2024 0970 354 000
Research Question/Objectives: What is the epidemiologic burden of RSV infections in children and adolescents ≤17 years old?
Objectives:
- Describe the frequency of infant hospitalizations due to RSV in Ontario by year and stratified by RSV seasonality, age, wGA at birth, birthweight, sex, geographic region, income quintile, and risk status
- Describe in-hospital, all-cause mortality among infant hospitalizations with RSV in Ontario by year and stratified by RSV seasonality, age, wGA at birth, birthweight, sex, geographic region, income quintile, and risk status
- Describe the length of hospital stay for infants hospitalized with RSV in Ontario by year and stratified by RSV seasonality, age, wGA at birth, birthweight, sex, geographic region, income quintile, and risk status
- Describe length of stay in intensive care unit (ICU) and/or alternate level of care (ALC) for infants hospitalized with RSV in Ontario by year and stratified by RSV seasonality, age, wGA at birth, birthweight, sex, geographic region, income quintile, and risk status
- Describe complete hospitalization costs of infants hospitalized with RSV in Ontario by year and stratified by RSV seasonality, age, wGA at birth, birthweight, sex, geographic region, income quintile, risk status, and ICU utilization
Results: Completed
Results: May 2025
Private Sector Project
2026
Real-world study on the effectiveness of nirmatrelvir-ritonavir in reducing severe outcomes from COVID-19
Project ID: P2023-184/ 2026 0980 010
Project Year: 2026
Status: In progress
Private Sector Project
2026
CARE: A Canadian Real World Evidence Study of Brodalumab in Plaque Psoriasis to Understand the Impact on Quality of Life and Work Productivity
Project ID: P2024-226/ 2026 0980 009 000
Project Year: 2026
Status: In progress